C13.1 Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect

✓ Billable ICD-10-CM 2026
Open C13.1 in Web App →

The ICD-10-CM code for Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect is C13.1 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
C00-C14: Malignant neoplasms of lip, oral cavity and pharynx (C00-C14)
Category C13
6 codes (5 billable)
FY2026 Status
Stable since FY2024
Excludes2
Not included here. These conditions are coded elsewhere but may be coded together if applicable.
  • malignant neoplasm of aryepiglottic fold or interarytenoid fold, laryngeal aspect (C32.1)

Inclusion Terms

  • Malignant neoplasm of aryepiglottic fold, marginal zone
  • Malignant neoplasm of aryepiglottic fold NOS
  • Malignant neoplasm of interarytenoid fold, marginal zone
  • Malignant neoplasm of interarytenoid fold NOS

U.S. Hospital Utilization

  • An estimated 175 U.S. inpatient stays in 2023 included C13.1 among the documented diagnoses.
  • 55 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial